As illustrated in Fig. 2B, CCT5 was significantly upregulated in 16 cancer types, including BLCA, BRCA, CESC, CHOL, COAD, ESCA, GBM, HNSC, KIRP, LIHC, LUAD, LUSC, PRAD, READ, STAD, and UCEC, and significantly downregulated in two distinct cancer types, KICH and THCA. Here, CCT5 is linked to cancer.